Fine Organic Q1 FY27: consolidated PAT +18% YoY as margins expand past own guided range
PAT +17.98% YoY · revenue +17.98% · margins expanding
₹694.17 Cr
+17.98% YoY
₹138.14 Cr
+17.98% YoY
19.23%
+0.6pp YoY
₹45.06
Fine Organic Industries' consolidated results for the quarter ended June 30, 2026 (Q1 FY27) show revenue from operations of Rs.694.17 Cr, up 18.0% YoY (Rs.588.38 Cr) and 11.0% QoQ (Rs.625.32 Cr), against management's own Q4 FY26-concall guidance of "flat revenue growth for FY27 and FY28" driven mainly by price rather than volume. Consolidated PAT came in at Rs.138.14 Cr, +18.0% YoY as reported; because the year-ago quarter carried a Rs.6.98 Cr one-off insurance gain (final settlement of a January 2024 plant-fire claim) that inflates the base, adjusted YoY PAT growth is closer to ~23.5%. Consolidated EPS was Rs.45.06 versus Rs.38.19 a year ago. No exceptional item was booked this quarter. Standalone PAT was Rs.135.50 Cr, up 46.0% YoY reported (~54.4% adjusted for the same prior-year one-off).
Q1 FY-2027 vs prior quarters
Margins expanded on both bases. Consolidated operating profitability (PBT + depreciation + finance costs - other income, as a % of revenue) came to roughly 25.1% this quarter versus ~22.2% a year ago and ~20.6% last quarter - comfortably above the 18-20% "sustainable" EBITDA range management flagged on the last call. The expansion traces mainly to cost of materials consumed falling to 56.7% of revenue from 61.3% a year ago, alongside a large build in finished-goods/WIP inventory (change in inventories of Rs.(15.30) Cr, i.e. inventory increased) that reduced the cost line for the quarter - consistent with price realisation running ahead of input costs, the driver management itself pointed to for FY27. Employee costs and other expenses grew roughly in line with revenue (other expenses Rs.92.19 Cr vs Rs.74.46 Cr YoY), and the Group's share of joint-venture losses widened to Rs.1.93 Cr from Rs.0.72 Cr a year ago - a modest drag not separately addressed in this filing.
The stock went into the print at ₹5,199.9, up 5% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 2 consecutive quarters; revenue is at a 6-quarter high.
Management anticipates flat revenue growth for FY27 and FY28 due to existing capacities operating at full utilization, with any top-line increase primarily driven by price rather than volume. Growth is expected to resume post-commissioning of the SEZ plant in India (expected H2 FY28) and the U.S. plant. Sustainable EBI
— This quarter: beat
No quarter-specific Street estimate for Q1 FY27 turned up in a web search - coverage was limited to full-year FY27 commentary and the board-meeting announcement - so vsStreet is marked unknown rather than inferred. Versus management's own framing, the quarter runs well ahead of the "flat, price-led" revenue guidance and above the 18-20% EBITDA-margin band set out on the Q4 FY26 call; no updated FY27 outlook accompanies this filing, and no separate press release or investor note was available in the record to quote. The quarter's other developments - a Rs.11.33 Cr insurance claim settled for the 2024 plant fire (Jul 31), senior-management retirement alongside exchange penalties (Jul 10), the FY26 BRSR filing and AGM notice for Aug 18 - are governance/compliance items with no direct read-through to this quarter's P&L. Note 2 to the results also flags the July 2026 residual settlement of the same fire claim (Rs.4.35 Cr, Rs.2.55 Cr incremental), absorbed into normal expense lines rather than shown as a separate exceptional item - a minor item worth flagging for anyone reconciling expense-line movements.
W1
Whether the ~25% operating margin print holds or reverts toward management's guided 18-20% 'sustainable' EBITDA band in coming quarters.
W2
SEZ plant (India, guided commissioning H2 FY28) and US plant progress - the next volume-growth triggers management flagged after a 'flat, price-led' FY27/FY28.
W3
Joint-venture losses (Fine Zeelandia, Thailand JV) - track whether the Rs.1.93 Cr quarterly drag narrows or widens.
Fine Organic Q1 FY27: Insurance Tailwind & Recovery Path
The settled ₹11.34 Cr insurance claim from July's plant fire should provide a one-time PAT boost. The real test: whether operational momentum from FY26's 4.3% growth sustains in an uneven macro, and how fast manufacturing recovery gains traction.
The Setup: One-Time Gain Masks the Real Question
Fine Organic's Q1 print will be shaped by two offsetting forces: the ₹11.34 Cr insurance settlement (a clean one-time gain that landed in July) and the operational disruption from the plant fire that preceded it. The Street's attention will split between the PAT kicker from the claim and whether core revenue growth — 4.3% in FY26 — can hold up in Q1's tougher seasonality and a macro environment that has kept specialty chemicals under pressure.
~₹580–620 Cr
On-plan for Q1 seasonality; FY26 annual ₹2,366 Cr suggests Q1 at ~25% run-rate
~20–21%
FY26 full-year margin was 20.4%; Q1 likely inline or slightly compressed by plant recovery costs
₹11.34 Cr
Settled Jul 31; will show in Q1 PBT/PAT. Offset by disruption costs, likely net positive to PAT by ₹7–9 Cr range
FY27 trajectory unclear
No FY27 guidance issued yet; the call will telegraph whether 4–5% growth is sustainable or if macro headwinds are tightening
A strong Q1 would show revenue holding near ₹600 Cr (or above), EBITDA margin at 20%+ despite disruption, and a credible near-term recovery plan for the plant. Management would frame the insurance settlement as the trough, with growth resuming in Q2. A weak Q1 would be revenue below ₹580 Cr, margin compression below 20%, and cautious FY27 guidance that signals macro softness is persisting. Any miss on core operations (vs. the one-time gain) would raise questions about pricing power and customer demand.
On Track? FY26 to FY27 Trajectory
Fine Organic closed FY26 with 4.3% revenue growth and 1.6% PAT growth — steady but unspectacular. EBITDA was ₹483 Cr on revenue of ₹2,366 Cr (20.4% margin). The company has been guiding a steady-state, mature specialty-chemicals story: low-to-mid single-digit volume growth, margin pressure from raw-material volatility, and a strong balance sheet (dividend of ₹11/share approved). Q1 FY27 will reveal whether that run-rate holds. The plant fire and July settlement are noise; the signal is whether organic growth is slowing or stable. Investors will want to hear management address: Are customer orders for Q2+ firming, or is macro caution building? Is the company maintaining pricing or ceding share?
What the Street Says
Since Last Quarter: Disruption and Transition
1 · Insurance Claim Settled (Jul 31, 2026)
Fine Organic confirmed full settlement of ₹11.33 Cr from Tata AIG General Insurance for the plant fire. The claim covers property damage and business interruption. One-time gain will hit Q1 PBT; expect net PAT impact of ₹7–9 Cr after accounting for disruption costs and tax.
2 · Senior Management Retirements (Jul 10, 2026)
Two Senior Vice Presidents retired: Dr. Vijay Prabhu and Dr. Mayukh Warawdekar. Routine succession; no material operational risk flagged. Promoter ownership unchanged at 75%; no pledges or transfers disclosed.
3 · FY26 Annual Report & AGM Notice (Jul 27, 2026)
FY26 full-year results re-confirmed: Revenue ₹2,366 Cr (+4.3% YoY), EBITDA ₹483 Cr, PAT ₹417.1 Cr (+1.6% YoY). Board recommended ₹11 dividend. AGM scheduled Aug 18. BRSR (sustainability report) filed. All routine.
4 · Income Tax Demand (Apr 28, 2026, AY 2016-17)
Received tax assessment order from IT Dept for AY 2016-17; demand ~₹56.05 L. Minor, likely contested or in appeals process. No material impact to results or balance sheet.
5 · Trading Window Closed (Jul 1, 2026)
Standard insider-trading blackout ahead of Q1 result announcement. Re-opens post-disclosure.
The Watch List: Three Things to Track on Aug 7
1 · Core Revenue Growth (Ex-Insurance)
Strip out the one-time gain and check organic revenue vs. expectations (~₹580–620 Cr). Did the plant disruption dent orders, or has demand remained resilient? This is the proxy for macro sentiment.
2 · EBITDA Margin & Disruption Costs
Watch for commentary on plant recovery timelines and incremental costs. A margin hold above 20% despite disruption would be reassuring; a dip below 20% raises questions about operational gearing.
3 · FY27 Guidance & Tone
The company rarely gives formal FY guidance, but management commentary on order books, customer outlook, and macro headwinds will signal confidence. Any tone shift (more cautious) vs. FY26 calls would reset investor expectations.
Fine Organic heads into Q1 with a one-time insurance tailwind that will flatter near-term earnings, but the real story is whether the company's 4.3% FY26 growth trajectory holds up. The plant fire has been resolved, the insurance is settled, and management transitions are routine. The market's focus will be on core revenue and EBITDA margin — the proof that the company can maintain pricing power and operational discipline in a softening macro. Expect a modest beat on PAT (thanks to the insurance), but the sell-side and long-term holders will parse the operating performance and management's confidence on FY27 carefully.
Result date: Aug 7, 2026 (Board approval).